Ads
related to: what tests determine multiple myeloma cancer prognosis life expectancyexplorefrog.com has been visited by 10K+ users in the past month
alternativebee.com has been visited by 10K+ users in the past month
benchmarkguide.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Multiple myeloma is the second-most prevalent blood cancer (10%) after non-Hodgkin's lymphoma. [154] It represents about 1.8% of all new cancers and 2.1% of all cancer deaths. [7] Multiple myeloma affects slightly more men than women.
The goal of treatment for ET and PV is prevention of thrombohemorrhagic complications. The goal of treatment for MF is amelioration of anemia, splenomegaly, and other symptoms. Low-dose aspirin is effective in PV and ET. Tyrosine kinase inhibitors like imatinib have improved the prognosis of CML patients to near-normal life expectancy. [14]
Most cases of SPB progress to multiple myeloma within 2–4 years of diagnosis, but the overall median survival for SPB is 7–12 years. 30–50% of extramedullary plasmacytoma cases progress to multiple myeloma with a median time of 1.5–2.5 years. 15–45% of SPB and 50–65% of extramedullary plasmacytoma are disease free after 10 years. [3]
Some people with multiple myeloma don't have any symptoms, but bloods tests can determine the diagnosis. Symptoms that may appear could include bone pain, weakness, anemia, frequent infections ...
Light chain multiple myeloma is diagnosed in patients who have: a) the criteria for diagnosis of multiple myeloma except having a serum free light chain ratio outside the normal range of 0.26 to 1.65 without evidence of an intact immunoglobulin or free heavy chain; or b) an extreme free light chain ratio, i.e. outside the range of 0.02 to 100 ...
Serum B-cell maturation antigen (sBCMA) is the cleaved form of B-cell maturation antigen (BCMA), found at low levels in the serum of normal patients and generally elevated in patients with multiple myeloma (MM). [5] Changes in sBCMA levels have been found to correlate with a MM patient’s clinical status in response to treatment. [6] [7]
Ads
related to: what tests determine multiple myeloma cancer prognosis life expectancyexplorefrog.com has been visited by 10K+ users in the past month
alternativebee.com has been visited by 10K+ users in the past month
benchmarkguide.com has been visited by 10K+ users in the past month